Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial

被引：0
|
作者：
Xiao-Bing Yang
Wan-yin Wu
Shun-qin Long
Hong Deng
Zong-Qi Pan
Wen-Feng He
Yu-Shu Zhou
Gui-Ya Liao
Qiu-Ping Li
Shu-Jing Xiao
Jiao-Zhi Cai
机构：
[1] Guangdong Provincial Hospital of Traditional Chinese Medicine,Department of Oncology
来源：
Trials | / 16卷
关键词：
Non-small cell lung cancer; Chinese herbal medicine; decoction; Gefitinib; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations
    Kimihide Yoshida
    Yasushi Yatabe
    Jangchul Park
    Shizu Ogawa
    Ji Young Park
    Junichi Shimizu
    Yoshitsugu Horio
    Keitaro Matsuo
    Tetsuya Mitsudomi
    Toyoaki Hida
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 527 - 535
  • [42] Effect of Fuzheng Kangai granule and gefitinib on non-small cell lung cancer:a randomized double-blinded controlled trial
    赵越洋
    China Medical Abstracts(Internal Medicine), 2021, 38 (01) : 11 - 11
  • [43] A prospective phase II study of gefitinib in non-small cell cancer patients with epidermal growth factor receptor gene (EGFR) mutations
    Sugio, K.
    Uramoto, H.
    Oyama, T.
    Onizuka, T.
    Ichiki, Y.
    Yasuda, M.
    Sugaya, M.
    Nozoe, T.
    Takenoyama, M.
    Hanagiri, T.
    Yasumoto, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations
    Igawa, Satoshi
    Sasaki, Jiichiro
    Otani, Sakiko
    Ishihara, Mikiko
    Takakura, Akira
    Katagiri, Masato
    Masuda, Noriyuki
    ONCOLOGY, 2015, 89 (05) : 275 - 280
  • [45] Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small cell lung cancer
    Mu, XL
    Li, LY
    Zhang, XT
    Wang, MZ
    Feng, RE
    Cui, QC
    Zhou, HS
    Guo, BQ
    CLINICAL CANCER RESEARCH, 2005, 11 (12) : 4289 - 4294
  • [46] CLINICAL STUDY OF BUFEI HUAYU DECOCTION COMBINED WITH GEFITINIB IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
    Feng Yuan
    Chen Sining
    Zhou Ying
    Xia Ze
    Lin Weinan
    Zhu Lin
    Song Shenge
    Wei Lulu
    Li Jianzhe
    Tang Fangmei
    Jiang Ying
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1815 - 1821
  • [47] Gefitinib (iressa)-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small cell lung cancer
    Mu, X
    Li, L
    Zhang, X
    Wang, M
    Feng, R
    Cui, Q
    Zhou, H
    Guo, B
    LUNG CANCER, 2005, 49 : S110 - S111
  • [48] Single-agent gefitinib with concurrent radiotherapy for locally advanced non-small cell lung cancer harboring mutations of the epidermal growth factor receptor
    Okamoto, Isamu
    Takahashi, Toshiaki
    Okamoto, Hiroaki
    Nakagawa, Kazuhiko
    Watanabe, Koshiro
    Nakamatsu, Kiyoshi
    Nishimura, Yasumasa
    Fukuoka, Masahiro
    Yamamoto, Nobuyuki
    LUNG CANCER, 2011, 72 (02) : 199 - 204
  • [49] First-line gefitinib therapy for elder advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Multicenter phase II trial (NEJ 003 study)
    Minegishi, Y.
    Maemondo, M.
    Okinaga, S.
    Morikawa, N.
    Inoue, A.
    Kobayashi, K.
    Harada, M.
    Hagiwara, K.
    Nukiwa, T.
    Gemma, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION AND ACQUIRED RESISTANCE TO GEFITINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Li, Chenglin
    Zhou, Fengfeng
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1489 - 1493
12345